Cas:1093107-56-2 2-Bromo-6,7-dihydro-4H-pyrano[4,3-d][1,3]thiazole manufacturer & supplier

We serve Chemical Name:2-Bromo-6,7-dihydro-4H-pyrano[4,3-d][1,3]thiazole CAS:1093107-56-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Bromo-6,7-dihydro-4H-pyrano[4,3-d][1,3]thiazole

Chemical Name:2-Bromo-6,7-dihydro-4H-pyrano[4,3-d][1,3]thiazole
CAS.NO:1093107-56-2
Synonyms:qc-8792;2-Bromo-6,7-dihydro-4H-pyrano[4,3-d][1,3]thiazole;4H-Pyrano[4,3-d]thiazole, 2-bromo-6,7-dihydro-
Molecular Formula:C6H6BrNOS
Molecular Weight:220.087
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:310.9±32.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.618
PSA:50.36000
Exact Mass:218.935333
LogP:2.85

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like qc-8792 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4H-Pyrano[4,3-d]thiazole, 2-bromo-6,7-dihydro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4H-Pyrano[4,3-d]thiazole, 2-bromo-6,7-dihydro- Use and application,2-Bromo-6,7-dihydro-4H-pyrano[4,3-d][1,3]thiazole technical grade,usp/ep/jp grade.


Related News: One of the engineered IgM antibodies, IGM-6268, demonstrated a significantly increased potency against the original SARS-CoV-2 and emerging variants such as the current U.K., South African, and Brazilian variants of concern (VOC) and variants of interest (VOI) 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride (1:1) manufacturers Lonza’s Nansha site is fully integrated within the company’s global manufacturing network. Scientists and engineers based in Nansha focus on API development and manufacturing for customers around the globe. 2-(2,6-dichloro-4-methylphenoxy)ethanol suppliers Japan on Friday approved the administration of AstraZeneca Plc’s (AZN.L) COVID-19 vaccine after a few months’ pause due to fears about potential side effects, local media reported. methyl (1S,3R,4R)-3-hydroxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopentane-1-carboxylate vendor & factory.